Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 67296-1893

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 67296-1893). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (5 mg (100 Tablet Bottle))

Package Label-principal Display Panel (5 mg (100 Tablet Bottle))
The text provides information about a medication named Cyclobenzaprine Hydrochloride USP 5 mg distributed by Rising Pharma Holdings, Inc. It includes details such as the manufacturer location in India, package size of 100 tablets, storage instructions, and the drug code. This medication is used for muscle relaxation and may be indicated for various conditions.*
FDA Label Image

Package Label-principal Display Panel (10 mg (100 Tablet Bottle))

Package Label-principal Display Panel (10 mg (100 Tablet Bottle))
This is information about Cyclobenzaprine Hydrochloride tablets in 10mg. The usual adult dosage is one tablet per day according to the label. The tablets are distributed by Rising Pharma Holdings, Inc. and manufactured in India. Store the tablets at 20° to 25°C (68 to 77°F). The text also mentions not to print certain dotted lines on the packaging.*
FDA Label Image

Chemical Structure (Cyclobenz Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.